Aeolus Pharmaceuticl Stock Current Valuation
| AOLS Stock | USD 0.0001 0.00 0.00% |
Valuation analysis of Aeolus Pharmaceuticl helps investors to measure Aeolus Pharmaceuticl's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Aeolus Pharmaceuticl's price fluctuation is very steady at this time. Calculation of the real value of Aeolus Pharmaceuticl is based on 3 months time horizon. Increasing Aeolus Pharmaceuticl's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Aeolus pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Aeolus Pharmaceuticl. Since Aeolus Pharmaceuticl is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aeolus Pink Sheet. However, Aeolus Pharmaceuticl's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Aeolus Pharmaceuticl's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Aeolus Pharmaceuticl's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Aeolus Pharmaceuticl helps investors to forecast how Aeolus pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aeolus Pharmaceuticl more accurately as focusing exclusively on Aeolus Pharmaceuticl's fundamentals will not take into account other important factors: Aeolus Pharmaceuticl Company Current Valuation Analysis
Aeolus Pharmaceuticl's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Aeolus Pharmaceuticl Current Valuation | 167.29 K |
Most of Aeolus Pharmaceuticl's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aeolus Pharmaceuticl is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Aeolus Pharmaceuticl has a Current Valuation of 167.29 K. This is 100.0% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Aeolus Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aeolus Pharmaceuticl's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Aeolus Pharmaceuticl could also be used in its relative valuation, which is a method of valuing Aeolus Pharmaceuticl by comparing valuation metrics of similar companies.Aeolus Pharmaceuticl is currently under evaluation in current valuation category among its peers.
Aeolus Fundamentals
| Return On Equity | -1.86 | |||
| Return On Asset | -0.9 | |||
| Operating Margin | (5.31) % | |||
| Current Valuation | 167.29 K | |||
| Shares Outstanding | 152.09 M | |||
| Price To Earning | (2.37) X | |||
| Price To Book | 0.81 X | |||
| Price To Sales | 0.22 X | |||
| Revenue | 2.08 M | |||
| Gross Profit | (805 K) | |||
| EBITDA | (3.85 M) | |||
| Net Income | (3.56 M) | |||
| Cash And Equivalents | 403 K | |||
| Debt To Equity | 0.30 % | |||
| Current Ratio | 1.30 X | |||
| Book Value Per Share | 0 X | |||
| Cash Flow From Operations | (3.11 M) | |||
| Earnings Per Share | (0.03) X | |||
| Target Price | 1.25 | |||
| Beta | -3.96 | |||
| Market Capitalization | 167.29 K | |||
| Total Asset | 4.17 M | |||
| Retained Earnings | (184.68 M) | |||
| Working Capital | 3.16 M | |||
| Current Asset | 4.13 M | |||
| Current Liabilities | 972 K | |||
| Z Score | -61.6 | |||
| Net Asset | 4.17 M |
About Aeolus Pharmaceuticl Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aeolus Pharmaceuticl's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aeolus Pharmaceuticl using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aeolus Pharmaceuticl based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Aeolus Pink Sheet Analysis
When running Aeolus Pharmaceuticl's price analysis, check to measure Aeolus Pharmaceuticl's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aeolus Pharmaceuticl is operating at the current time. Most of Aeolus Pharmaceuticl's value examination focuses on studying past and present price action to predict the probability of Aeolus Pharmaceuticl's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aeolus Pharmaceuticl's price. Additionally, you may evaluate how the addition of Aeolus Pharmaceuticl to your portfolios can decrease your overall portfolio volatility.